- call +1-201-465-4211
- email sales@mrinsights.biz
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
Scope of the Report:
The worldwide market for Hospital Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Hospital Injectable Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
AstraZeneca
Gilead
Sciences
Merck & Co.
Novartis AG
Johnson & Johnson
Novo Nordisk A/S
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cardiology & Metabolic disorders
Neurology
Oncology
Autoimmune
Gastroenterology
Hematology
Pain
Infectious diseases
Others
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
E-commerce
There are 15 Chapters to deeply display the global Hospital Injectable Drugs market.
Chapter 1, to describe Hospital Injectable Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hospital Injectable Drugs, with sales, revenue, and price of Hospital Injectable Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hospital Injectable Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hospital Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hospital Injectable Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Hospital Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Cardiology & Metabolic disorders
1.2.2 Neurology
1.2.3 Oncology
1.2.4 Autoimmune
1.2.5 Gastroenterology
1.2.6 Hematology
1.2.7 Pain
1.2.8 Infectious diseases
1.2.9 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 E-commerce
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter International Inc.
2.1.1 Business Overview
2.1.2 Hospital Injectable Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter International Inc. Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Hospital Injectable Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer Inc.
2.3.1 Business Overview
2.3.2 Hospital Injectable Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Inc. Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline plc
2.4.1 Business Overview
2.4.2 Hospital Injectable Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline plc Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Hospital Injectable Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Gilead
2.6.1 Business Overview
2.6.2 Hospital Injectable Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Gilead Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sciences
2.7.1 Business Overview
2.7.2 Hospital Injectable Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sciences Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck & Co.
2.8.1 Business Overview
2.8.2 Hospital Injectable Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck & Co. Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis AG
2.9.1 Business Overview
2.9.2 Hospital Injectable Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis AG Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Hospital Injectable Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novo Nordisk A/S
2.11.1 Business Overview
2.11.2 Hospital Injectable Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novo Nordisk A/S Hospital Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital Injectable Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Hospital Injectable Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hospital Injectable Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hospital Injectable Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Hospital Injectable Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Hospital Injectable Drugs Market Analysis by Regions
4.1 Global Hospital Injectable Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Hospital Injectable Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hospital Injectable Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
4.5 South America Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
5 North America Hospital Injectable Drugs by Countries
5.1 North America Hospital Injectable Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Hospital Injectable Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hospital Injectable Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
6 Europe Hospital Injectable Drugs by Countries
6.1 Europe Hospital Injectable Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Hospital Injectable Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hospital Injectable Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
6.3 UK Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
6.4 France Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hospital Injectable Drugs by Countries
7.1 Asia-Pacific Hospital Injectable Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hospital Injectable Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hospital Injectable Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
7.5 India Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
8 South America Hospital Injectable Drugs by Countries
8.1 South America Hospital Injectable Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Hospital Injectable Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hospital Injectable Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hospital Injectable Drugs by Countries
9.1 Middle East and Africa Hospital Injectable Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hospital Injectable Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hospital Injectable Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Hospital Injectable Drugs Sales and Growth Rate (2013-2018)
10 Global Hospital Injectable Drugs Market Segment by Type
10.1 Global Hospital Injectable Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hospital Injectable Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Hospital Injectable Drugs Revenue and Market Share by Type (2013-2018)
10.2 Cardiology & Metabolic disorders Sales Growth and Price
10.2.1 Global Cardiology & Metabolic disorders Sales Growth (2013-2018)
10.2.2 Global Cardiology & Metabolic disorders Price (2013-2018)
10.3 Neurology Sales Growth and Price
10.3.1 Global Neurology Sales Growth (2013-2018)
10.3.2 Global Neurology Price (2013-2018)
10.4 Oncology Sales Growth and Price
10.4.1 Global Oncology Sales Growth (2013-2018)
10.4.2 Global Oncology Price (2013-2018)
10.5 Autoimmune Sales Growth and Price
10.5.1 Global Autoimmune Sales Growth (2013-2018)
10.5.2 Global Autoimmune Price (2013-2018)
10.6 Gastroenterology Sales Growth and Price
10.6.1 Global Gastroenterology Sales Growth (2013-2018)
10.6.2 Global Gastroenterology Price (2013-2018)
10.7 Hematology Sales Growth and Price
10.7.1 Global Hematology Sales Growth (2013-2018)
10.7.2 Global Hematology Price (2013-2018)
10.8 Pain Sales Growth and Price
10.8.1 Global Pain Sales Growth (2013-2018)
10.8.2 Global Pain Price (2013-2018)
10.9 Infectious diseases Sales Growth and Price
10.9.1 Global Infectious diseases Sales Growth (2013-2018)
10.9.2 Global Infectious diseases Price (2013-2018)
10.10 Others Sales Growth and Price
10.10.1 Global Others Sales Growth (2013-2018)
10.10.2 Global Others Price (2013-2018)
11 Global Hospital Injectable Drugs Market Segment by Application
11.1 Global Hospital Injectable Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacy Sales Growth (2013-2018)
11.3 Retail Pharmacy Sales Growth (2013-2018)
11.4 E-commerce Sales Growth (2013-2018)
12 Hospital Injectable Drugs Market Forecast (2018-2023)
12.1 Global Hospital Injectable Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Hospital Injectable Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Hospital Injectable Drugs Market Forecast (2018-2023)
12.2.2 Europe Hospital Injectable Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hospital Injectable Drugs Market Forecast (2018-2023)
12.2.4 South America Hospital Injectable Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hospital Injectable Drugs Market Forecast (2018-2023)
12.3 Hospital Injectable Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Hospital Injectable Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Hospital Injectable Drugs Market Share Forecast by Type (2018-2023)
12.4 Hospital Injectable Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Hospital Injectable Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Hospital Injectable Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Hospital Injectable Drugs Picture
Table Product Specifications of Hospital Injectable Drugs
Figure Global Sales Market Share of Hospital Injectable Drugs by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
